CHANTIBODY
LIVE

Serial Number

98125029

Owner

Chantibody Therapeutics Inc.

Attorney

Nazly Aileen Bayramoglu

First Use Date

Nov 5, 2022

Filing Date

Aug 9, 2023

Add to watchlist:

No watchlists yet
View on USPTO

CHANTIBODY Trademark

Serial Number: 98125029 • Registration: 7472341

CHANTIBODY is a trademark filed by Chantibody Therapeutics Inc. on August 9, 2023. The trademark is classified under Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Chantibody Therapeutics Inc. (5 trademarks)

1440 OBRIEN DR STE C MENLO PARK,
California, CA 940251432

Entity Type: 03

Trademark Details

Filing Date

August 9, 2023

Registration Date

August 13, 2024

First Use Anywhere

November 5, 2022

First Use in Commerce

November 5, 2022

Published for Opposition

May 28, 2024

Goods & Services

Research and development services performed for others in the fields of drug discovery, drug discovery products, pharmaceuticals, medicinal diagnostics, and biological products; Laboratory research and development services relating to the production of antibodies; Research and development services in the field of antibodies; Medical and Scientific research and development in the fields of cancer, immunological-inflammatory chronic conditions, tissue repair, biology, laboratory testing, biotechnology, biochemistry, and medicine; Research and product development services for others in the fields of cancer, immunological-inflammatory chronic conditions, tissue repair, biology, laboratory testing, biotechnology, biochemistry, and medicine; Providing information on the subject of scientific research in the fields of cancer, immunological-inflammatory chronic conditions, tissue repair, biology, laboratory testing, biotechnology, biochemistry, and medicine; Biotechnology research; Pharmaceutical research and development; Pharmaceutical research services; Scientific and technological services, namely, research and development in the field of discovery, design, and development of antigen-binding molecules, using artificial intelligence and other computer-aided computational techniques, and laboratory services relating to the aforesaid molecular discovery, design, and development

Filing History

TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Jul 22, 2026 EWAF
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jul 22, 2026 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jul 22, 2026 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jul 22, 2026 REAP
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Aug 13, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Aug 13, 2024 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 28, 2024 NPUB
PUBLISHED FOR OPPOSITION
May 28, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 8, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 22, 2024 CNSA
ASSIGNED TO EXAMINER
Apr 9, 2024 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Sep 12, 2023 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 10, 2023 NWOS
NEW APPLICATION ENTERED
Aug 12, 2023 NWAP